Takeda Pharmaceutical (4502:JP) (TAK) PT Lowered to JPY5,200 at Citi
Tweet
Share
E-mailGet Alerts 4502:JP Hot Sheet
Price: $0.00 --0%
Rating Summary:
0 Buy, 0 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 17 | Down: 10 | New: 10
Rating Summary:
0 Buy, 0 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 17 | Down: 10 | New: 10
Trade Now!
Join SI Premium – FREE
Citi analyst Hidemaru Yamaguchi lowered the price target on Takeda Pharmaceutical (4502:JP) (NYSE: TAK) to JPY5,200.00 (from JPY5,400.00) while maintaining a Buy rating.
You May Also Be Interested In
- Eni SpA (ENI:IM) (E) PT Raised to EUR11 at Barclays
- ASM International NV (ASM:NA) PT Raised to EUR330 at Barclays
- Rogers Communications (RCI/B:CN) (RCI) PT Raised to Cdn$75 at RBC Capital
Create E-mail Alert Related Categories
Analyst Comments, Analyst PT Change, Intl RatingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
